Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Asthma

  Free Subscription


Articles published in Pulm Pharmacol Ther

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    December 2018
  1. LOMBARDI C, Bagnasco D, Caruso C, D'Amato M, et al
    Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.
    Pulm Pharmacol Ther. 2018 Dec 28. pii: S1094-5539(18)30277.
    PubMed     Text format     Abstract available


    November 2018
  2. PELAIA C, Calabrese C, Barbuto S, Busceti MT, et al
    Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
    Pulm Pharmacol Ther. 2018 Nov 7. pii: S1094-5539(18)30245.
    PubMed     Text format     Abstract available


    September 2018
  3. SULAIMAN I, Tan K, Mohtarrudin N, Woei Lim JC, et al
    Andrographolide prevented toluene diisocyanate-induced occupational asthma and aberrant airway E-cadherin distribution via p38 MAPK-dependent Nrf2 induction.
    Pulm Pharmacol Ther. 2018 Sep 20. pii: S1094-5539(18)30150.
    PubMed     Text format     Abstract available


  4. CALZETTA L, Hanania NA, Dini FL, Goldstein MF, et al
    Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomised studies (DOROTHEO 1 and DOROTHEO 2).
    Pulm Pharmacol Ther. 2018 Sep 13. pii: S1094-5539(18)30182.
    PubMed     Text format     Abstract available


  5. PELAIA C, Busceti MT, Solinas S, Terracciano R, et al
    Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study.
    Pulm Pharmacol Ther. 2018 Sep 11. pii: S1094-5539(18)30212.
    PubMed     Text format     Abstract available


    August 2018
  6. MASELLI DJ, Hanania NA
    Asthma COPD overlap: Impact of associated comorbidities.
    Pulm Pharmacol Ther. 2018 Aug 30. pii: S1094-5539(18)30142.
    PubMed     Text format     Abstract available


  7. MARQUES DE MELLO L, Cruz AA
    A proposed scheme to cope with comorbidities in asthma.
    Pulm Pharmacol Ther. 2018 Aug 24. pii: S1094-5539(18)30137.
    PubMed     Text format     Abstract available


    July 2018
  8. BUDDE J, Skloot GS
    Is aging a "comorbidity" of asthma?
    Pulm Pharmacol Ther. 2018 Jul 4. pii: S1094-5539(18)30138.
    PubMed     Text format     Abstract available


  9. HASSALL D, Brealey N, Wright W, Hughes S, et al
    Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD.
    Pulm Pharmacol Ther. 2018 Jul 4. pii: S1094-5539(18)30084.
    PubMed     Text format     Abstract available


    June 2018
  10. LUCZAK-WOZNIAK K, Dabrowska M, Domagala I, Miszczuk M, et al
    Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors.
    Pulm Pharmacol Ther. 2018 Jun 28. pii: S1094-5539(18)30076.
    PubMed     Text format     Abstract available


    April 2018
  11. SCADUTO F, Giglio RV, Benfante A, Nikolic D, et al
    Serum lipoproteins are not associated with the severity of asthma.
    Pulm Pharmacol Ther. 2018 Apr 4. pii: S1094-5539(18)30052.
    PubMed     Text format     Abstract available


    February 2018
  12. JOHANSSON EL, Ternesten-Hasseus E, Gustafsson P, Pullerits T, et al
    Small and large airway reactions to osmotic stimuli in asthma and chronic idiopathic cough.
    Pulm Pharmacol Ther. 2018 Feb 10. pii: S1094-5539(17)30291.
    PubMed     Text format     Abstract available


  13. KACZYNSKA K, Zajac D, Wojciechowski P, Kogut E, et al
    Neuropeptides and breathing in health and disease.
    Pulm Pharmacol Ther. 2018;48:217-224.
    PubMed     Text format     Abstract available


  14. AKABA T, Komiya K, Suzaki I, Kozaki Y, et al
    Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells.
    Pulm Pharmacol Ther. 2018;48:117-123.
    PubMed     Text format     Abstract available


  15. HUR J, Kang JY, Rhee CK, Kim YK, et al
    The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-beta signaling.
    Pulm Pharmacol Ther. 2018;48:5-14.
    PubMed     Text format     Abstract available


    December 2017
  16. SOULELE K, Macheras P, Karalis V
    On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches.
    Pulm Pharmacol Ther. 2017 Dec 6. pii: S1094-5539(17)30180.
    PubMed     Text format     Abstract available


    October 2017
  17. HEANEY LG
    Cough and severe asthma.
    Pulm Pharmacol Ther. 2017 Oct 3. pii: S1094-5539(17)30149.
    PubMed     Text format    


    September 2017
  18. BALKI A, Balamurugan S, Bardapurkar S, Dalal S, et al
    Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Pulm Pharmacol Ther. 2017 Sep 7. pii: S1094-5539(17)30099.
    PubMed     Text format     Abstract available


    June 2017
  19. BENFANTE A, Messina R, Milazzo V, Scichilone N, et al
    How to unveil chronic respiratory diseases in clinical practice? A model of alliance between general practitioners and pulmonologists.
    Pulm Pharmacol Ther. 2017;44:106-110.
    PubMed     Text format     Abstract available


  20. SPOSATO B, Scalese M, Latorre M, Novelli F, et al
    Can the response to Omalizumab be influenced by treatment duration? A real-life study.
    Pulm Pharmacol Ther. 2017;44:38-45.
    PubMed     Text format     Abstract available


    February 2017
  21. CHEN M, Shi J, Zhang W, Huang L, et al
    MiR-23b controls TGF-beta1 induced airway smooth muscle cell proliferation via direct targeting of Smad3.
    Pulm Pharmacol Ther. 2017;42:33-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: